Behavioural Science may reduce Vaccine Hesitancy
According to a study published on JAMA Network Open, behavioural science personalized email reminders can effectively reduce the suspicion of vaccines by healthcare professionals. E-mails based on social norms prompted 6.5% of recipients to schedule appointments with the vaccine, and reconsidering the risks of e-mails convinced 6.9% of recipients. Standards, recalibration risks and submission to the authorities as factors affecting the reduction of vaccination. The volatility of vaccination among health care providers remains high, and some health systems are turning to vaccination prescriptions to reach unwilling health care workers.
The AMA recently announced its support for mandatory vaccination against COVID19 by healthcare providers. The view is that the Patient-Centered Outcome Institute recently approved $11 million in research funding to reduce vaccine fluctuations among healthcare providers. He is likely to develop a safe and effective vaccine in early 2021.
The United States needs a national strategy to promote the COVID19 vaccine, combining the urgency and commitment of “distorting speed action” with innovative methods of behavioural science and social marketing to increase the confidence and acceptance of the COVID19 vaccine among different populations. The behavioural science of the National COVID19 Vaccine Promotion Program. There are still many uncertainties in the proposals of these strategies: the time for approval or approval of one or more vaccines; the safety and effectiveness characteristics of the vaccine; the implementation of priority plans by state and local authorities; the existing vaccination plans and channels are promoting and Potential for spreading the COVID19 vaccine; increased politicization of vaccine approval and acceptance.
Given the importance of acting quickly, a national organization like Operation Warp Speed should lead federal efforts to promote the COVID19 vaccine. If the organization can have important decision-making power and resource allocation power, it will help. Carry out nationwide social marketing activities; disseminate vaccine promotion guidelines and provide services for introducing vaccines into local vaccination plans, and train doctors to communicate with patients on vaccination. Several behaviour-based strategies, as well as similar innovations in vaccine trust and advocacy, can help bridge the last mile to achieve a successful national COVID19 vaccination plan. Collecting and analyzing data on reasons for adoption and reluctance is critical to the development of effective vaccine delivery and information delivery methods.
The use of vaccines focuses on the attitudes of some low-income and low- and middle-income countries towards the COVID19 vaccine. In these samples, LMIC accepted an average of 80 people.3%, from 66.5% to 96.6%, with an average of 78%. Russia and the United States, the two reference countries, have low acceptance of the COVID19 vaccine, which is consistent with the low level of trust in pre-pandemic vaccines for children in these countries. The countries are shown in Table 2. For example, the low adoption rates of the COVID19 vaccine we have seen in Russia and the United States may reflect this particular pandemic and the politicization of vaccine development 49,50,51,52 and broader general suspicion of vaccines. The reason and unwillingness to get the COVID19 vaccine, and the type of source that respondents trust the most when deciding whether to get the COVID19 vaccine.